Tech Company Financing Transactions
PLx Pharma Funding Round
PLx Pharma, operating out of Houston, secured $15 million from private investors.
Transaction Overview
Company Name
Announced On
3/5/2019
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 2 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
8285 El Rio 130
Houston, TX 77054
USA
Houston, TX 77054
USA
Phone
Website
Email Address
Overview
PLx Pharma is a pharmaceutical company developing the next generation of non-steroidal anti-inflammatory agents (NSAIDs) that are safer on the gut.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Michael Valentino
Chief Executive Officer
Natasha Giordano
Chief Financial Officer
Rita O'Connor
Chief Medical Officer
Efthymios Deliargyris
Vice President
Upendra Marathi
VP - Marketing
Michael Dillon
VP - Regulatory Affairs
Estela Chong
VP - Sales
Steven Valentino
Browse more venture capital transactions:
Prev: 3/5/2019: Scytale venture capital transaction
Next: 3/5/2019: Paradox venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs